AVEO Oncology
AVEO
#7479
Rank
โ‚น48.90 B
Marketcap
โ‚น1,407
Share price
0.00%
Change (1 day)
186.24%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -โ‚น2.24 Billion

According to AVEO Oncology 's latest financial reports the company's current earnings are โ‚น94.31 Million. In 2021 the company made an earning of -โ‚น5.01 Billion a decrease over its 2020 earnings that were of -โ‚น3.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚น2.24 Billion-55.28%
2021 -โ‚น5.01 Billion49.9%
2020 -โ‚น3.34 Billion-479.04%
2019 โ‚น0.88 B-276.17%
2018 -โ‚น0.5 Billion-91.79%
2017 -โ‚น6.09 Billion142.38%
2016 -โ‚น2.52 Billion78.51%
2015 -โ‚น1.41 Billion-71.55%
2014 -โ‚น4.95 Billion-50.72%
2013 -โ‚น10.04 Billion-4.88%
2012 -โ‚น10.56 Billion-426.29%
2011 โ‚น3.23 B-159.85%
2010 -โ‚น5.41 Billion35.33%
2009 -โ‚น4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚น3.260 T-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.036 T-38,159.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น41.74 B-1,632.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น533.30 B-19,683.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.062 T-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚น0.22 Billion-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA